Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004972 |
YEM_ID: | YEM-306 |
XU_ID: | XU-351 |
ID: | TCMBANKHE004972/YEM-306/XU-351 |
植物拉丁名: |
|
功能与主治: | To quicken blood and dispel stasis, disperse swelling and relieve pain./Amenorrhea and dysmenorrhea, postpartum blood stasis, stabbing pain in chest and abdomen, swelling pain due to external injury. |
药用植物名: | 苏木 |
药名: | 苏木 |
来源: | 云南民族药物志：第二卷|云南省昭通市盐津县 |
药用部位: | heartwood|壳 |
使用民族: | 阿昌族/傣族/德昂族/哈尼族/基诺族/景颇族/傈僳族/瑶族/彝族/藏族/壮族 |
药味: | Mild; Pungent; Sweet; Salty |
经络: | Spleen; Liver; Heart |
治疗类型: | 活血化淤 |
KUMST_ID1: | KMUST-BS-0363 |
KUMST_ID2: | KMUST-202312150008-1，-2 |
TCM_ID_id: | 4597 |
TCMSP_id: | 673 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN003145 | 10-o-methyl protosappanin b | 10-o-methylprotosappanin b | C17H18O6 | 318.32 g/mol | COC1=C(C=C2C(=C1)CC(COC3=C2C=CC(=C3)O)(CO)O)O |
| TCMBANKIN003221 | 7,3′,4′-trihydroxy-3-benzyl-2H-chromene | C16H14O4 | C1C(=CC2=C(O1)C=C(C=C2)O)CC3=CC(=C(C=C3)O)O | ||
| TCMBANKIN006028 | brazilein | C16H12O5 | 284.26 | C1C2=CC(=C(C=C2C3=C4C=CC(=O)C=C4OCC31O)O)O | |
| TCMBANKIN006114 | tetraacetylbrazilin | Tetraacetylbrazilin; Brazilin tetraacetate; Brx-019; AC1OCFZ1; [(6aS,11bR)-6a,9,10-triacetyloxy-7,11b-dihydro-6H-indeno[2,1-c]chromen-3-yl] acetate | C24H22O9 | 454.4 g/mol | CC(=O)OC1=CC2=C(C=C1)C3C4=CC(=C(C=C4CC3(CO2)OC(=O)C)OC(=O)C)OC(=O)C |
| TCMBANKIN008731 | brasilin | C16H14O5 | 286.28 g/mol | C1C2=CC(=C(C=C2C3C1(COC4=C3C=CC(=C4)O)O)O)O | |
| TCMBANKIN011023 | 3-deoxyaconitine | C34H47NO10 | 629.74 | CCN1CC2(CCC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC(=O)C)OC)OC)COC | |
| TCMBANKIN011664 | 3,7-dimethyl-1,3,6-octadiene | ||||
| TCMBANKIN017204 | dibenzoxocin | C15H12O2 | 0 | C1C2OC(C3=CC=CC=C31)C4=CC=CC=C4O2 | |
| TCMBANKIN020424 | protosappanin cdimethyl acetal | C18H20O7 | COC(C1(CC2=CC(=C(C=C2C3=C(C=C(C=C3)O)OC1)O)O)O)OC | ||
| TCMBANKIN020865 | beta-sitsterol | 0 | |||
| TCMBANKIN024857 | bonducellin | C17H14O4 | 282.29 g/mol | COC1=CC=C(C=C1)C=C2COC3=C(C2=O)C=CC(=C3)O | |
| TCMBANKIN028809 | protosappanin a, b, c | ||||
| TCMBANKIN030140 | 3-dibenzofuransulfonic acid | FR-0115; SBB007690; dibenzofuran-3-sulfonic acid | C12H8O4S | 248.25 | C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)S(=O)(=O)O |
| TCMBANKIN031059 | sappanin | C12H10O4 | 218.209 | C1=CC(=C(C=C1C2=C(C=C(C=C2)O)O)O)O | |
| TCMBANKIN036854 | brazilin | brasilin; 7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10 (6H)-tetrol | C16H14O5 | 286.28 g/mol | C1C2=CC(=C(C=C2C3C1(COC4=C3C=CC(=C4)O)O)O)O |
| TCMBANKIN036984 | hematein | C16H12O6 | 300.26 g/mol | C1C2=CC(=C(C=C2C3=C4C=CC(=O)C(=C4OCC31O)O)O)O | |
| TCMBANKIN037218 | 3,8''-Biapigenin | 538.5 g/mol | |||
| TCMBANKIN037275 | 1,3,4,5-Tetracaffeoylquinic acid | 840.7 g/mol | |||
| TCMBANKIN037452 | protosappanin a dimethyl acetal | protosappanin a dimethyl acetal | C17H18O6 | 318.32 g/mol | COC1(CC2=CC(=C(C=C2C3=C(C=C(C=C3)O)OC1)O)O)OC |
| TCMBANKIN039315 | protosappanin e1 | protosappanin e-1 | C32H26O11 | 586.54 | C1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(C4OC56CC7=CC(=C(C=C7C5(O4)C8=C(C=C(C=C8)O)OC6)O)O)O)O)O |
| TCMBANKIN039840 | neoprotosappanin | neoprotosappanin | C33H28O10 | 585 | c1(O[H])c([H])c(OC([H])([H])[C@](O[H])([C@@](c2c([H])c3c(OC([H])([H])[C@](O[H])([C@@]([H])(C([H])([H])[H])c(c([H])c(O[H])c(O[H])c4[H])c45)[C@@]35[H])c([H])c2O[H])([H])c(c([H])c(O[H])c(O[H])c6[H])c67)[ C@]78[H])c8c([H])c1[H] |
| TCMBANKIN040181 | 3'-deoxy-4-o-methylsappanol | C17H18O5 | 302.32 g/mol | COC1C2=C(C=C(C=C2)O)OCC1(CC3=CC=C(C=C3)O)O | |
| TCMBANKIN040344 | Sappanone B | 302.279 | |||
| TCMBANKIN040535 | Episappanol | C16H16O6 | 304.295 | c1(O[H])c([H])c(OC([H])([H])[C@](O[H])(C([H])([H])c2c([H])c(O[H])c(O[H])c([H])c2[H])[C@@]3(O[H])[H])c3c([H])c1[H] | |
| TCMBANKIN040767 | Sappanol | 304.29 | |||
| TCMBANKIN041193 | 3-deoxysappanone B | C16H14O5 | 286.279 | c1(O[H])c([H])c(OC([H])([H])[C@]([H])(C([H])([H])c2c([H])c([H])c(O[H])c(O[H])c2[H])C3=O)c3c([H])c1[H] | |
| TCMBANKIN041272 | stearic acid | 4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (*Sodium salt*); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (*Sodium salt*); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10 | C18H36O2 | 284 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O |
| TCMBANKIN041899 | Protosappanin A | C15H12O5 | 272.253 | c12c(c([H])c([H])c(O[H])c1[H])c3c(c([H])c(O[H])c(O[H])c3[H])C([H])([H])C(=O)C([H])([H])O2 | |
| TCMBANKIN043203 | 3'-O-Methyl brazilin | 3'-o-methylbrazilin | C17H16O5 | 300.306 | c1(O[H])c([H])c(OC([H])([H])[C@@](O[H])(C([H])([H])c(c([H])c(OC([H])([H])[H])c(O[H])c2[H])c23)[C@@]34[H])c4c([H])c1[H] |
| TCMBANKIN043278 | Ombuin | NSC 675952; BDBM50240614; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-1-benzopyran-4-one; kaempferol-7,4'-dimethylether; 3,5-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromone; CHEMBL75589; FLAVONE, 4',7-DIMETHOXY-3,3',5-TRIHYDROXY-; Quercetin 4',7-dimethyl ether; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4H-chromen-4-one; Quercetin-7,4'-Dimethyl Ether; CHEBI:67493; AC1NSZAJ; DTXSID00200942; MolPort-039-338-131; LS-68977; Ambap529-40-8; Z3K3F0YR3W; CJ-26550; AIDS-071739; NSC-675952; NSC675952; ombuin; CTK8J0348; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxychromen-4-one; OMBUINE; 3,5,3'-Trihydroxy-7,4'-dimethoxyflavone; 4',7-Dimethoxy-3,3',5-trihydroxyflavone; 4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-; 529-40-8; ZINC1645590; 4',7-Dimethylquercetin; 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-4-chromenone; LMPK12112652; 5-18-05-00498 (Beilstein Handbook Reference); quercetin 7,4'-dimethyl ether; UNII-Z3K3F0YR3W; 7,4'-dimethylquercetin; AIDS071739; BRN 0338215; 4'',7-dimethylquercetin; ST24041236; 3,5-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromen-4-one; quercetin-7,4''-dimethyl ether; 7,4'-Di-O-methylquercetin; 3,5-Dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromen-4-one; SCHEMBL1252211 | C17H14O7 | 330.29 | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)OC)O)O)O |
| TCMBANKIN043942 | 3,9-Dihydroxypterocarp-6a-ene | ||||
| TCMBANKIN044688 | protostemonine | Isoprotostemonine | C23H31NO6 | 417 | N12[C@@]([H])(C([H])([H])C([H])([H])[C@@]1([H])[C@]3([H])C([H])([H])[C@]([H])(C([H])([H])[H])C(=O)O3)[C@]4([H])[C@]([H])(O\C(=C(/C(OC([H])([H])[H])=C(C([H])([H])[H])C5=O)\O5)\[C@@]4([H])C([H])([H])[H] )C([H])([H])C([H])([H])C2([H])[H] |
| TCMBANKIN046218 | protosappanin c | C16H14O6 | 302.28 g/mol | C1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(C=O)O)O)O | |
| TCMBANKIN047354 | 7-hydroxy-3-(4'-hydroxybenzylidene)-chroman-4-one | C16H12O4 | 268.26 g/mol | C1C(=CC2=CC=C(C=C2)O)C(=O)C3=C(O1)C=C(C=C3)O | |
| TCMBANKIN047960 | neosappanone a | C33H28O11 | 600.6 g/mol | COC1C2(CC3=CC(=C(C=C3C14C=C(C(=O)C=C4OC2)C5C6(CC7=CC(=C(C=C7C58C=CC(=O)C=C8OC6)O)O)O)O)O)O | |
| TCMBANKIN049587 | protosappanin b | C16H16O6 | 304.29 | C1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(CO)O)O)O | |
| TCMBANKIN049642 | 4'-O-Methyltaxifolin | 318.28 g/mol | |||
| TCMBANKIN058060 | gallic acid | Spectrum4_001544; NSC-755825; 4CN-0954; KBio2_000822; NCGC00260064-01; KBio3_001168; CHEBI:30778; GTPL5549; D0Y3TZ; NCGC00091125-01; 632XD903SP; ARONIS23903; Spectrum5_000108; Jsp002851; T7419; Gallic acid, puriss., 98.0%; I14-9302; NCGC00091125-07; ZINC1504; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); KBioGR_002008; AK-65266; pyrogallol-5-carboxylate; BRD-K77345217-001-01-9; Gallicum acidum; LNTHITQWFMADLM-UHFFFAOYSA-N; KBio2_003390; EBD679760; NCGC00091125-04; AJ-08037; Gallic acid; ZB000350; BG01502846; A808977; (?)-Gallic acid; WLN: QVR CQ DQ EQ; N1830; AC1NEVA5; SBB008781; 149-91-7; GALLIC ACID ANHYDROUS; Gallic acid [NF]; KS-00000IWM; CS-8191; LS-870; C01424; KS-00004784; CHEBI:16918; SPECTRUM210369; c0006; UNII-632XD903SP; ACMC-20aku5; CTK0H5618; BIDD:ER0374; AC1Q732X; NCGC00091125-02; F1908-0156; Oprea1_087792; CG0029; DSSTox_RID_75711; Kyselina 3,4,5-trihydroxybenzoova; 3-10-00-02070 (Beilstein Handbook Reference); RP23206; NSC36997; Gallic acid, certified reference material, TraceCERT(R); AI3-16412; CCG-38670; STK298718; Tox21_202515; bmse000389; AN-15162; AB00052697_03; SR-05000001537-2; NSC-36997; 1886-EP2374526A1; 5-Carboxybenzene-1,2,3-triol; KBio2_005958; SR-05000001537-3; NCGC00091125-05; KBio1_001347; Kyselina gallova [Czech]; KSC175M1R; KBioSS_000822; HMS2091A07; gallate; CPD-183; Spectrum3_000254; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; gallic acid ; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; GDE; SBI-0052184.P002; EINECS 205-749-9; CAS-149-91-7; Kyselina gallova; J3.617.291F; Benzoic acid, 3,4,5-trihydroxy-; BG00601456; DivK1c_006403; Benzoic acid,4,5-trihydroxy-; gallic acid for microelectronic industrial; BRN 2050274; Gallic acid tech.; NCGC00091125-03; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid, 97.5-102.5% (titration); gallicacid; 3,4,5-Trihydroxybenzoic acid, anhydrous; NSC674319; TR-020762; 3,4,5-tris(oxidanyl)benzoate; MCULE-1552954312; Gallic acid polymer; Pharmakon1600-00210369; BSPBio_001668; Tox21_111089; HMS1923K07; CCRIS 5523; BDBM50085536; NSC-674319; ST2404570; BB_SC-2795; AC-1206; 3,4,5-trihydroxy-Benzoic acid; Gallic Acid Hydrate; AC1L1934; RTR-020762; GALOP; Q-201146; SR-05000001537-1; DSSTox_CID_650; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; 3,4,5-Trihydroxybenzoic acid ion; GALLICACID; s4603; CHEMBL288114; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; NSC755825; G0011; AB1002218; Gallic Acid, F; MolPort-000-881-260; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; PS-8710; SC-46383; FT-0626592; BBL009937; MFCD00002510; SpecPlus_000307; 3,4,5-trihydroxy-Benzoate; SCHEMBL15012; DSSTox_GSID_20650; ST083487; SR-05000001537; 3,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate, X; Tox21_111089_1; Gallic acid (Monohydrate or Anhydrous) (3,4,5-Trih; 3,4,5-Trihydroxybenzoic acid;; Z966690556; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; BC200279; Spectrum2_000399; HY-N0523; HSDB 2117; AC1Q732Y; DTXSID0020650; 5-Trihydroxybenzoic acid; AKOS000119625; NSC 20103; Gallic acid, tech; 138-57-8; NSC-20103; AIDS-001349; gallate; CPD-183; Spectrum3_000254; KBio2_000822; Gallic acid monohydrate; AIDS-059239; KBio3_001168; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; C01424; CHEBI:30778; EINECS 205-749-9; CHEBI:16918; NCGC00091125-01; c0006; J3.617.291F; SPECTRUM210369; Benzoic acid, 3,4,5-trihydroxy-; DivK1c_006403; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; Spectrum5_000108; NCGC00091125-02; BRN 2050274; Oprea1_087792; NCGC00091125-03; 3-10-00-02070 (Beilstein Handbook Reference); SpecPlus_000307; Kyselina 3,4,5-trihydroxybenzoova [Czech]; KBioGR_002008; AI3-16412; NSC674319; pyrogallol-5-carboxylate; 3,4,5-tris(oxidanyl)benzoate; AIDS001349; KBio2_003390; Gallic acid polymer; 1886-EP2374526A1; ZB000350; Gallic acid; BSPBio_001668; KBio2_005958; AIDS059239; CCRIS 5523; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; A808977; 27645_RIEDEL; KBio1_001347; 398225_SIAL; Kyselina gallova [Czech]; WLN: QVR CQ DQ EQ; Spectrum2_000399; HSDB 2117; G7384_SIGMA; KBioSS_000822; GALOP; AC1NEVA5; SBB008781; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; NSC 20103; 3,4,5-Trihydroxybenzoic acid ion; 149-91-7; 3,4,5-trihydroxybenzoic acid; Galllic acid | C7H6O5 | 170.12 | C1=C(C=C(C(=C1O)O)O)C(=O)O |
| TCMBANKIN058071 | gallic acid 3- o -(6-galloylglucoside) | Gallic acid-3-O-(6'-O-galloyl)glucoside; gallic acid-3-O-(6'-O-galloyl)-glucoside; 3,4-dihydroxy-5-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-2-tetrahydropyranyl]oxy]benzoic acid; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-2-yl]oxy-benzoic acid; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-2-yl]oxybenzoic acid; gallicacid-3-o-(6'-o-galloyl)glucoside; 3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-2-yl]oxy-benzoic acid; gallic acid-3-o-(6'-o-galloyl)-glucoside | C20H20O14 | 484.36 | C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC3=CC(=CC(=C3O)O)C(=O)O)O)O)O |
| TCMBANKIN058555 | protosappanin e1 | protosappanin e-1; protosappanin e-2 ; protosappanin e-2; protosappanin e2 | C32H26O11 | 586.54 | C1C2=CC(=C(C=C2C3=C(C=C(C=C3)O)OCC1(C4OC56CC7=CC(=C(C=C7C5(O4)C8=C(C=C(C=C8)O)OC6)O)O)O)O)O |
| TCMBANKIN058715 | (-)-methyl selina-3,11-dien-14-oate | (?)-methyl selina-3,11-dien-14-oate | C16H24O2 | CC(=C)C1CCC2(CCC=C(C2C1)C(=O)OC)C | |
| TCMBANKIN059198 | o-12'-methyl ergocornine; o-12'-methyl ergocorninine | C32H41N5O5+U2K2:V2J4K2:T2K2:U2 | CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)OC | ||
| TCMBANKIN059599 | taraxe-rol | C30H50O | 426.7 g/mol | CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)C)C | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061153 | Octacosanol;octacosanol-1;1-octacosanol | C28H58O | 410.8 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061382 | sarcosine | N- methyl glycine | C3H7NO2 | 89.09 g/mol | CNCC(=O)O |
| TCMBANKIN061417 | Ｍethyl brevifolin carboxylate | C14H10O8 | 306.22 g/mol | COC(=O)C1CC(=O)C2=C1C3=C(C(=C(C=C3C(=O)O2)O)O)O | |
| TCMBANKIN061515 | 3,5-dihydroxy-4-methoxybenzoicacid | 3,5-dihydroxy-4-methoxy-benzoic acid; Benzoic acid, 3,5-dihydroxy-4-methoxy-; 4-Methoxy-3,5-dihydroxybenzoic acid; 5-Hydroxyisovanillic acid; 4319-02-2; 3,5-Dihydroxy-4-methoxybenzoic acid; EINECS 224-346-9; 3,5-Dihydroxy-p-anisic acid; 4-O-Methylgallic acid | C8H8O5 | 184.15 g/mol | COC1=C(C=C(C=C1O)C(=O)O)O |
| TCMBANKIN061596 | chrysoeriol;5,7,4′-trihydroxy-3′-methoxyflavone;3'-methoxy-4',5,7-trihydroxyflavone | 35.850895 | C16H12O6 | 300.26 g/mol | COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN061625 | 3'-o-methyl episappanol | 3'-o-methylepisappanol;3'-o-methylsappanol; AC1NSYDD; 3-[(4-hydroxy-3-methoxyphenyl)methyl]-2,4-dihydrochromene-3,4,7-triol | C17H18O6 | 318.32 | COC1=C(C=CC(=C1)CC2(COC3=C(C2O)C=CC(=C3)O)O)O |
| TCMBANKIN061637 | sappanchalcone | sappanchalcone;2'-methoxy-3,4,4'-trihydroxychalcone | C16H14O5 | 286.28 g/mol | COC1=C(C=CC(=C1)O)C(=O)C=CC2=CC(=C(C=C2)O)O |
| TCMBANKIN061718 | Quercetin-7-Methyl ether | rhamnetin;Spectrum2_000642; 7-O-Methylquercetin; KBio2_004233; CCRIS 3792; 2-(3,4-Dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-1-benzopyran-4-one; BSPBio_003125; Spectrum3_001343; Spectrum5_000464; AIDS-003059; 7-Methoxyquercetin; C.I. 75690; 90-19-7; BRN 0047741; Quercetin 7-methyl ether; 5-18-05-00495 (Beilstein Handbook Reference); C10176; NCGC00095624-01; KBio1_001503; 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4-chromenone; SPECTRUM310031; Flavonoid;.beta.-Rhamnocitrin; KBio3_002345; NCGC00095624-02; NSC 19802; NCI60_001648; KBioSS_001665; SPBio_000643; AIDS003059; 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one; KBio2_001665; Rhamnetin; FLAVONE, 7-METHOXY-3,3',4',5-TETRAHYDROXY-; DivK1c_006559; 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-chromen-4-one; Flavone, 3,3',4',5-tetrahydroxy-7-methoxy- (8CI); 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy- (9CI); 17799_FLUKA; NSC19802; KBio2_006801; .beta.-Rhamnocitrin; 7-Methylquercetin; SDCCGMLS-0066624.P001; Flavone, 3,3',4',5-tetrahydroxy-7-methoxy-; beta-Rhamnocitrin; Spectrum4_001872; ST5331696; 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-chromone; KBioGR_002367; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-; EINECS 201-974-1; Spectrum_001185; SpecPlus_000463; 3,3',4',5-Tetrahydroxy-7-methoxyflavone | C16H12O7 | 316.26 g/mol | COC1=CC(=C2C(=C1)OC(=C(C2=O)O)C3=CC(=C(C=C3)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab